Inspire Medical Net Worth

Inspire Medical Net Worth Breakdown

  INSP
The net worth of Inspire Medical Systems is the difference between its total assets and liabilities. Inspire Medical's net worth represents the value of the company's equity or ownership interest. In other words, it is the amount of money that would be left over if all of Inspire Medical's assets were sold and all of its debts were paid off. Net worth is sometimes referred to as shareholder's equity or book value. Inspire Medical's net worth can be used as a measure of its financial health and stability which can help investors to decide if Inspire Medical is a good investment. It is also essential in determining the company's creditworthiness and ability to secure financing before investing in Inspire Medical Systems stock.

Inspire Medical Net Worth Analysis

Inspire Medical's net worth analysis, or its valuation, is the process of determining the total value of the company. This involves assessing a range of factors, including Inspire Medical's financial performance, assets, liabilities, and potential for growth. The ultimate goal is to provide a clear understanding of Inspire Medical's overall worth, which can help investors make informed investment decisions. There are several methods that can be used to perform Inspire Medical's net worth analysis. One common approach is to calculate Inspire Medical's market capitalization.Another approach is to use the price-to-earnings ratio (P/E ratio), which compares Inspire Medical's stock price to its earnings per share (EPS). Discounted cash flow (DCF) analysis is another popular method for assessing Inspire Medical's net worth. This approach calculates the present value of Inspire Medical's future cash flows, taking into account factors such as growth rate, profitability, and risk. By comparing the present value of Inspire Medical's cash flows to its current stock price, investors can gain a better understanding of the company's overall value. Finally, investors may use comparable company analysis to evaluate Inspire Medical's net worth. This involves comparing Inspire Medical's financial metrics to similar companies in the same industry. By identifying companies with similar financial characteristics, investors can gain insight into Inspire Medical's net worth relative to its peers.

Enterprise Value

6.09 Billion

To determine if Inspire Medical is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Inspire Medical's net worth research are outlined below:
The company reported the previous year's revenue of 624.8 M. Net Loss for the year was (21.15 M) with profit before overhead, payroll, taxes, and interest of 341.74 M.
Over 98.0% of the company shares are owned by institutional investors
Latest headline from zacks.com: Gear Up for Inspire Q1 Earnings Wall Street Estimates for Key Metrics
Inspire Medical uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Inspire Medical Systems. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Inspire Medical's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
6th of February 2024
Upcoming Quarterly Report
View
7th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
6th of February 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

Inspire Medical Target Price Consensus

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Inspire target price is determined by taking all analyst projections and averaging them out. There is no one specific way to measure analysts' performance other than comparing it to past results via a very sophisticated attribution analysis. Inspire Medical's target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, investor sentiment analysis, technical analysis, earnings estimate, and various momentum models.
   17  Strong Buy
Most Inspire analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to help potential investors understand Inspire stock's fair price compared to its market value. Analysts arrive at stock ratings after researching the public financial statements of Inspire Medical Systems, talking to its executives and customers, or listening to those companies' conference calls.
Macroaxis Advice   Exposure   Valuation

Inspire Medical Target Price Projection

Inspire Medical's current and average target prices are 157.94 and 274.75, respectively. The current price of Inspire Medical is the price at which Inspire Medical Systems is currently trading. On the other hand, Inspire Medical's target price is what analysts think the stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.

Current Price

Inspire Medical Market Quote on 8th of May 2024

Low Price157.94Odds
High Price157.94Odds

157.94

Target Price

Analyst Consensus On Inspire Medical Target Price

Low Estimate250.02Odds
High Estimate304.97Odds

274.75

Historical Lowest Forecast  250.02 Target Price  274.75 Highest Forecast  304.97
Note that most analysts generally publish their price targets in research reports on specific companies, along with recommendations for the company's stock.Although price targets are often quoted in the financial news media, there could be a delay between the publication of the latest analyst outlook on Inspire Medical Systems and the information provided on this page.

Know Inspire Medical's Top Institutional Investors

Have you ever been surprised when a price of an equity instrument such as Inspire Medical is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Inspire Medical Systems backward and forwards among themselves. Inspire Medical's institutional investor refers to the entity that pools money to purchase Inspire Medical's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Shares
Westfield Capital Management Company, Lp2023-12-31
545.6 K
Macquarie Group Ltd2023-12-31
538.6 K
State Street Corporation2023-12-31
531.2 K
Franklin Resources Inc2023-12-31
514 K
Ameriprise Financial Inc2023-12-31
491.3 K
Federated Hermes Inc2023-12-31
453.3 K
Geode Capital Management, Llc2023-12-31
444.8 K
Fred Alger Management, Llc2023-12-31
405.9 K
Bank Of New York Mellon Corp2023-12-31
398.5 K
Fmr Inc2023-12-31
3.3 M
Vanguard Group Inc2023-12-31
2.9 M
Note, although Inspire Medical's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Follow Inspire Medical's market capitalization trends

The company currently falls under 'Mid-Cap' category with a current market capitalization of 7.44 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Inspire Medical's market, we take the total number of its shares issued and multiply it by Inspire Medical's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Market Cap

6.26 Billion

Project Inspire Medical's profitablity

Inspire Medical's profitability indicators refer to fundamental financial ratios that showcase Inspire Medical's ability to generate income relative to its revenue or operating costs. If, let's say, Inspire Medical is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Inspire Medical's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Inspire Medical's profitability requires more research than a typical breakdown of Inspire Medical's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
Last ReportedProjected for Next Year
Return On Tangible Assets(0.03)(0.03)
Return On Capital Employed(0.07)(0.07)
Return On Assets(0.03)(0.03)
Return On Equity(0.04)(0.04)
The company has Profit Margin (PM) of (0.03) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of 0.05 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.05.
When accessing Inspire Medical's net worth, it's important to look at multiple sources and consider different scenarios. For example, gross profit margin measures Inspire Medical's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Inspire Medical's profitability and make more informed investment decisions.
The data published in Inspire Medical's official financial statements usually reflect Inspire Medical's business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Inspire Medical Systems. For example, before you start analyzing numbers published by Inspire accountants, it's critical to develop an understanding of what Inspire Medical's liquidity, profitability, and earnings quality are in the context of the Health Care Technology space in which it operates.
Please note, the presentation of Inspire Medical's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Inspire Medical's management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Inspire Medical's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Inspire Medical Systems. Please utilize our Beneish M Score to check the likelihood of Inspire Medical's management manipulating its earnings.

Evaluate Inspire Medical's management efficiency

Inspire Medical Systems has return on total asset (ROA) of (0.0405) % which means that it has lost $0.0405 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.0396) %, meaning that it created substantial loss on money invested by shareholders. Inspire Medical's management efficiency ratios could be used to measure how well Inspire Medical manages its routine affairs as well as how well it operates its assets and liabilities. As of 05/08/2024, Return On Tangible Assets is likely to drop to -0.03. In addition to that, Return On Capital Employed is likely to drop to -0.07. At this time, Inspire Medical's Total Current Liabilities is relatively stable compared to the past year. As of 05/08/2024, Liabilities And Stockholders Equity is likely to grow to about 710.7 M, while Non Current Liabilities Total is likely to drop slightly above 23.1 M.
Last ReportedProjected for Next Year
Book Value Per Share 19.54  20.52 
Net Current Asset Value 0.00  0.00 
Tangible Asset Value 0.00  0.00 
Tangible Book Value Per Share 19.54  20.52 
Enterprise Value Over EBITDA(144.03)(151.23)
Price Book Value Ratio 10.41  9.89 
Enterprise Value Multiple(144.03)(151.23)
Price Fair Value 10.41  9.89 
Enterprise Value5.8 B6.1 B
The analysis of Inspire Medical's management efficiency is an essential part of evaluating and assessing the financial and operational performance of the entity. It is also vital to analyze Inspire Medical's future growth prospects and the overall market conditions to determine the value and potential of its stock. The analysis involves studying a range of financial metrics such as revenue, earnings, profit margins, cash flow, debt, market share, and external factors such as economic trends, industry outlook, competition, and government regulations. The goal of Inspire Stock analysis is to determine whether it is undervalued, fairly valued, or overvalued and to make informed investment decisions.
Enterprise Value Revenue
10.5403
Revenue
624.8 M
Quarterly Revenue Growth
0.396
Revenue Per Share
21.323
Return On Equity
(0.04)
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Inspire Medical insiders, such as employees or executives, is commonly permitted as long as it does not rely on Inspire Medical's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Inspire Medical insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Inspire Medical Corporate Filings

8K
7th of May 2024
Report filed with the SEC to announce major events that shareholders should know about
ViewVerify
F4
6th of May 2024
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
ViewVerify
19th of March 2024
Other Reports
ViewVerify
13A
9th of February 2024
An amended filing to the original Schedule 13G
ViewVerify
Inspire Medical time-series forecasting models is one of many Inspire Medical's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Inspire Medical's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Inspire Medical Earnings Estimation Breakdown

The calculation of Inspire Medical's earning per share is based on the data from the past 12 consecutive months, used for reporting the company's financial figures. The next projected EPS of Inspire Medical is estimated to be -0.65 with the future projection ranging from a low of -0.85 to a high of -0.41. Please be aware that this consensus of annual earnings estimates for Inspire Medical Systems is based on EPS before non-recurring items and includes expenses related to employee stock options.
Last Reported EPS
0.49
-0.85
Lowest
Expected EPS
-0.65
-0.41
Highest

Inspire Medical Earnings Projection Consensus

Suppose the current estimates of Inspire Medical's value are higher than the current market price of the Inspire Medical stock. In this case, investors may conclude that Inspire Medical is overpriced and will exhibit bullish sentiment. On the other hand, if the present value is lower than the stock price, analysts may conclude that the market undervalues the equity. These scenarios may suggest that the market is not as efficient as it should be at the estimation time, and Inspire Medical's stock will quickly adjusts to the new information provided by the consensus estimate.
Number of AnalystsHistorical AccuracyLast Reported EPSEstimated EPS for 31st of March 2024Current EPS (TTM)
529.52%
0.49
-0.65
-0.71

Inspire Medical Earnings per Share Projection vs Actual

Actual Earning per Share of Inspire Medical refers to what the company shows during its earnings calls or quarterly reports. The Expected EPS is what analysts covering Inspire Medical Systems predict the company's earnings will be in the future. The higher the earnings per share of Inspire Medical, the better is its profitability. While calculating the Earning per Share, we use the weighted ratio, as the number of shares outstanding can change over time.

Inspire Medical Estimated Months Earnings per Share

For an investor who is primarily interested in generating an income out of investing in entities such as Inspire Medical, the EPS ratio can tell if the company is intending to increase its current dividend. Although EPS is an essential tool for investors, it should not be used in isolation. EPS of Inspire Medical should always be considered in relation to other companies to make a more educated investment decision.

Inspire Quarterly Analyst Estimates and Surprise Metrics

Earnings surprises can significantly impact Inspire Medical's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2024-03-19
2023-12-31-0.090.490.58644 
2023-11-07
2023-09-30-0.58-0.290.2950 
2023-08-01
2023-06-30-0.57-0.410.1628 
2023-05-02
2023-03-31-0.66-0.530.1319 
2023-02-07
2022-12-31-0.570.10.67117 
2022-11-01
2022-09-30-0.77-0.60.1722 
2022-08-02
2022-06-30-0.62-0.530.0914 
2022-05-03
2022-03-31-0.8-0.610.1923 
2022-02-08
2021-12-31-0.44-0.090.3579 
2021-11-02
2021-09-30-0.61-0.380.2337 
2021-08-03
2021-06-30-0.64-0.480.1625 
2021-05-04
2021-03-31-0.66-0.60.06
2021-02-23
2020-12-31-0.48-0.280.241 
2020-11-02
2020-09-30-0.72-0.390.3345 
2020-08-04
2020-06-30-1.1-0.880.2220 
2020-05-05
2020-03-31-0.57-0.67-0.117 
2020-02-25
2019-12-31-0.4-0.380.02
2019-11-05
2019-09-30-0.41-0.340.0717 
2019-08-06
2019-06-30-0.43-0.320.1125 
2019-05-07
2019-03-31-0.38-0.350.03
2019-02-26
2018-12-31-0.31-0.220.0929 
2018-11-06
2018-09-30-0.35-0.220.1337 
2018-08-07
2018-06-30-0.51-0.430.0815 
2018-06-07
2018-03-31-3.64-5.05-1.4138 
2018-02-28
2017-12-310-3.46-3.46
2017-05-04
2017-03-310-3.9-3.9

Be your own money manager

Our tools can tell you how much better you can do entering a position in Inspire Medical without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Efficient Frontier Now

   

Efficient Frontier

Plot and analyze your portfolio and positions against risk-return landscape of the market.
All  Next Launch Module

Inspire Medical Corporate Directors

Inspire Medical corporate directors refer to members of an Inspire Medical board of directors. The board of directors generally takes responsibility for the Inspire Medical's affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of Inspire Medical's board members must vote for the resolution. The Inspire Medical board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.
Georgia GarinoisMelenikiotouIndependent DirectorProfile
Megan CPADirector ReportingProfile
Casey TanseyIndependent DirectorProfile
Gary EllisIndependent DirectorProfile

How to buy Inspire Stock?

The net worth of Inspire Medical Systems is the difference between its total assets and liabilities. Inspire Medical's net worth represents the value of the company's equity or ownership interest. In other words, it is the amount of money that would be left over if all of Inspire Medical's assets were sold and all of its debts were paid off. Net worth is sometimes referred to as shareholder's equity or book value. Inspire Medical's net worth can be used as a measure of its financial health and stability which can help investors to decide if Inspire Medical is a good investment. It is also essential in determining the company's creditworthiness and ability to secure financing before investing in Inspire Medical Systems stock.

Already Invested in Inspire Medical Systems?

The danger of trading Inspire Medical Systems is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Inspire Medical is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Inspire Medical. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Inspire Medical Systems is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Inspire Medical Systems is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Inspire Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Inspire Medical Systems Stock. Highlighted below are key reports to facilitate an investment decision about Inspire Medical Systems Stock:
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Inspire Medical Systems. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in state.
You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.

Complementary Tools for Inspire Stock analysis

When running Inspire Medical's price analysis, check to measure Inspire Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Inspire Medical is operating at the current time. Most of Inspire Medical's value examination focuses on studying past and present price action to predict the probability of Inspire Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Inspire Medical's price. Additionally, you may evaluate how the addition of Inspire Medical to your portfolios can decrease your overall portfolio volatility.
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
CEOs Directory
Screen CEOs from public companies around the world
Is Inspire Medical's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Inspire Medical. If investors know Inspire will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Inspire Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
3.682
Earnings Share
(0.71)
Revenue Per Share
21.323
Quarterly Revenue Growth
0.396
Return On Assets
(0.04)
The market value of Inspire Medical Systems is measured differently than its book value, which is the value of Inspire that is recorded on the company's balance sheet. Investors also form their own opinion of Inspire Medical's value that differs from its market value or its book value, called intrinsic value, which is Inspire Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Inspire Medical's market value can be influenced by many factors that don't directly affect Inspire Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Inspire Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Inspire Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Inspire Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.